青少年和年轻成人霍奇金淋巴瘤应按儿童还是成人方案治疗?
该研究纳入2012至2018年在圣路易医院治疗的148例新诊断霍奇金淋巴瘤患者(15-25岁),其中71例接受成人方案、77例接受儿童方案。5年总生存率为100%,5年无进展生存率为85%,两治疗组间无显著差异(儿童组85% vs 成人组86%,p=0.7)。早期预后良好期5年无进展生存率为100%,晚期为78%。
要点
- 儿童方案短期类固醇和长春新碱相关毒性风险更高。
- 成人方案因蒽环类、丙卡巴肼、博来霉素和放疗暴露更高,预期晚期毒性风险更高。
- 青少年和年轻成人霍奇金淋巴瘤患者无论采用何种治疗策略,结局均优异。
核心结论
- 结果证实青少年和年轻成人霍奇金淋巴瘤患者无论采用何种治疗策略,结局均优异。
- 结果支持量身定制的治疗决策,并强调在配备受训专业人员的专门单元中管理青少年和年轻成人患者的重要性。
研究设计与样本
- 研究纳入2012年至2018年在圣路易医院治疗的148例新诊断霍奇金淋巴瘤患者,年龄15-25岁。
- 71例接受成人方案治疗,77例接受儿童方案治疗。
主要发现
- 5年总生存率为100%,5年无进展生存率为85%。
- 5年无进展生存率在两治疗组间无显著差异(儿童组85% vs 成人组86%,p=0.7)。
- 总体5年无进展生存率在早期预后良好期为100%,在晚期为78%。
- 儿童方案观察到短期类固醇和长春新碱相关毒性风险更高。
- 成人方案因蒽环类、丙卡巴肼、博来霉素和放疗暴露更高,预期晚期毒性风险更高。
临床怎么用
- 作者认为结果支持量身定制的治疗决策。
- 作者强调在配备受训专业人员的专门单元中管理青少年和年轻成人患者的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hodgkin lymphoma (HL) is one of the most common cancers in adolescents and young adults (AYA). Paediatric and adult therapeutic strategies diverge while sharing the common objective: maintaining optimal efficacy with less long-term toxicity. However, few studies have compared the outcome of AYA treated according to one or the other approaches. Among the 148 patients aged 15-25 years, treated at Saint-Louis Hospital for newly diagnosed HL between 2012 and 2018, 71 were treated according to an adult protocol and 77 were treated according to a paediatric one. The 5-year overall survival (OS) and progression-free survival (PFS) were, respectively, 100% and 85%, with no significant difference between treatment groups (85% in paediatric vs. 86% in adult, p = 0.7). Overall, the 5-year PFS was 100% for early favourable stages and 78% for advanced stages. A higher risk of short-term steroid and vincristine-related toxicities was observed in paediatric regimen, whereas a higher risk of late toxicities was expected in adult regimen, due to higher anthracyclines, procarbazine, bleomycin and radiotherapy exposure. These results confirm the excellent outcome of AYA patients with HL, whatever the treatment strategies. They justify a tailor-made therapeutic decision and highlight the importance of managing AYA patients in dedicated units with trained professionals.
引用
- Lew-Derivry L, Chevillon F, Brice P, et al. Should adolescents and young adults with Hodgkin lymphoma be treated as children or adults? Br J Haematol. 2025. PMID: 39756437. doi:10.1111/bjh.19985
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。